Sljedeći

Auto Play

Minimum Residual Disease in Acute Lymphoblastic Leukemia

5 Pogledi • 08/04/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play